Subtopic Deep Dive
Aberrant Splicing in Disease
Research Guide
What is Aberrant Splicing in Disease?
Aberrant splicing in disease refers to mutations or dysregulation in pre-mRNA splicing processes that produce dysfunctional isoforms contributing to pathologies like muscular dystrophies and neurodegenerative disorders.
Aberrant splicing arises from mutations affecting splice sites, leading to exon skipping or inclusion errors observed in diseases such as Duchenne muscular dystrophy (Blake et al., 2002, 1206 citations). Tools like Human Splicing Finder predict these splicing signals from genomic variants (Desmet et al., 2009, 2480 citations). Alternative splicing dysregulation links to cancer and neurodegeneration via altered protein isoforms (Kornblihtt et al., 2013, 848 citations).
Why It Matters
Aberrant splicing drives Duchenne muscular dystrophy through dystrophin gene mutations, lacking effective treatments until splicing modulation therapies emerged (Blake et al., 2002). In neurodegenerative diseases, splicing errors in proteins like FUS and Tau promote toxic phase separation and aggregation (Monahan et al., 2017; Ambadipudi et al., 2017). Targeting splicing with antisense oligonucleotides offers precision medicine for genetic disorders, as predicted by tools like Human Splicing Finder (Desmet et al., 2009). These approaches address unmet needs in muscular dystrophies and frontotemporal dementia.
Key Research Challenges
Predicting Splicing Mutations
Distinguishing pathogenic splicing variants from benign ones requires accurate signal prediction amid synonymous and intronic mutations. Human Splicing Finder addresses this but struggles with deep intronic variants (Desmet et al., 2009). Validation demands functional assays linking predictions to disease phenotypes.
Quantifying Isoform Dysregulation
Measuring disease-specific splice isoform ratios in patient tissues faces technical variability in RNA-seq data. Alternative splicing complexity complicates isoform-specific expression tracking (Kornblihtt et al., 2013). Standardization across cohorts remains unresolved.
Developing Splicing Therapies
Antisense oligonucleotides for exon skipping show promise in dystrophinopathies but face delivery and off-target challenges (Blake et al., 2002). Translating predictions from tools like Human Splicing Finder to clinical efficacy requires optimized targeting (Desmet et al., 2009).
Essential Papers
Human Splicing Finder: an online bioinformatics tool to predict splicing signals
François-Olivier Desmet, Dalil Hamroun, Marine Lalande et al. · 2009 · Nucleic Acids Research · 2.5K citations
Thousands of mutations are identified yearly. Although many directly affect protein expression, an increasing proportion of mutations is now believed to influence mRNA splicing. They mostly affect ...
Protein Phase Separation: A New Phase in Cell Biology
Steven Boeynaems, Simon Alberti, Nicolas L. Fawzi et al. · 2018 · Trends in Cell Biology · 2.0K citations
The functional role of long non-coding RNA in human carcinomas
Ewan A. Gibb, Carolyn J. Brown, Wan L. Lam · 2011 · Molecular Cancer · 1.7K citations
Function and Genetics of Dystrophin and Dystrophin-Related Proteins in Muscle
Derek J. Blake, Andrew Weir, Sarah E. Newey et al. · 2002 · Physiological Reviews · 1.2K citations
The X-linked muscle-wasting disease Duchenne muscular dystrophy is caused by mutations in the gene encoding dystrophin. There is currently no effective treatment for the disease; however, the compl...
Untranslated regions of mRNAs.
Flavio Mignone, Carmela Gissi, Sabino Liuni et al. · 2002 · Genome Biology · 971 citations
Alternative splicing: a pivotal step between eukaryotic transcription and translation
Alberto R. Kornblihtt, Ignacio E. Schor, Mariano Alló et al. · 2013 · Nature Reviews Molecular Cell Biology · 848 citations
Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression?
Jessica L. Bell, Kristin Wächter, Britta Mühleck et al. · 2012 · Cellular and Molecular Life Sciences · 787 citations
The insulin-like growth factor-2 mRNA-binding proteins 1, 2, and 3 (IGF2BP1, IGF2BP2, IGF2BP3) belong to a conserved family of RNA-binding, oncofetal proteins. Several studies have shown that these...
Reading Guide
Foundational Papers
Start with Desmet et al. (2009) for splicing prediction tools essential to identifying disease variants, then Blake et al. (2002) for dystrophinopathy mechanisms, followed by Kornblihtt et al. (2013) for splicing regulation basics.
Recent Advances
Study Monahan et al. (2017) on FUS phosphorylation disrupting phase separation in neurodegeneration, and Ambadipudi et al. (2017) on Tau liquid-liquid phase separation linked to splicing errors.
Core Methods
Core techniques include splice site prediction (Human Splicing Finder), RNA-seq for isoform quantification, antisense oligonucleotides for modulation, and phase separation assays for proteinopathy studies.
How PapersFlow Helps You Research Aberrant Splicing in Disease
Discover & Search
Research Agent uses searchPapers and exaSearch to find splicing mutation literature, then citationGraph on Desmet et al. (2009) reveals 2480-cited works linking variants to diseases like muscular dystrophy. findSimilarPapers expands to therapeutic modulation studies from Blake et al. (2002).
Analyze & Verify
Analysis Agent applies readPaperContent to extract splicing predictions from Desmet et al. (2009), then verifyResponse with CoVe checks variant pathogenicity claims against RNA-seq data. runPythonAnalysis performs statistical verification of isoform ratios using pandas on uploaded patient datasets, with GRADE scoring evidence strength for therapeutic claims.
Synthesize & Write
Synthesis Agent detects gaps in splicing therapy coverage across muscular dystrophy papers, flagging contradictions in phase separation roles (Monahan et al., 2017). Writing Agent uses latexEditText and latexSyncCitations to draft reviews with Desmet et al. (2009), then latexCompile generates figures via exportMermaid for splice site diagrams.
Use Cases
"Analyze splicing isoform ratios in Duchenne muscular dystrophy RNA-seq data"
Research Agent → searchPapers('dystrophin splicing mutations') → Analysis Agent → runPythonAnalysis(pandas isoform quantification, matplotlib ratio plots) → statistical output with p-values and GRADE scores.
"Write LaTeX review on antisense therapies for aberrant splicing"
Synthesis Agent → gap detection in Blake et al. (2002) therapies → Writing Agent → latexEditText(structured sections) → latexSyncCitations(Desmet 2009) → latexCompile(PDF with splice diagrams).
"Find code for predicting splicing signals from variants"
Research Agent → searchPapers('Human Splicing Finder implementations') → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → downloadable Python scripts for variant analysis.
Automated Workflows
Deep Research workflow conducts systematic review of 50+ aberrant splicing papers, chaining searchPapers → citationGraph → GRADE grading for disease links like dystrophinopathies. DeepScan applies 7-step analysis with CoVe checkpoints to verify splicing predictions from Desmet et al. (2009) against patient data. Theorizer generates hypotheses on phase separation in splicing-related neurodegeneration from Monahan et al. (2017).
Frequently Asked Questions
What defines aberrant splicing in disease?
Aberrant splicing involves mutations disrupting splice sites or regulatory elements, producing toxic or non-functional mRNA isoforms in diseases like Duchenne muscular dystrophy (Blake et al., 2002) and neurodegeneration.
What methods predict splicing mutations?
Human Splicing Finder predicts signals from genomic variants, scoring splice sites and exonic enhancers affected by synonymous mutations (Desmet et al., 2009).
What are key papers on this topic?
Desmet et al. (2009, 2480 citations) introduced Human Splicing Finder; Blake et al. (2002, 1206 citations) detailed dystrophin splicing in muscular dystrophy; Kornblihtt et al. (2013, 848 citations) reviewed alternative splicing mechanisms.
What open problems exist?
Challenges include deep intronic variant prediction, isoform quantification in tissues, and safe delivery of splicing-modulating oligonucleotides for clinical use.
Research RNA Research and Splicing with AI
PapersFlow provides specialized AI tools for your field researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
AI Academic Writing
Write research papers with AI assistance and LaTeX support
Start Researching Aberrant Splicing in Disease with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
Part of the RNA Research and Splicing Research Guide